Shares of Verici Dx plc (LON:VRCI – Get Free Report) were down 9.4% during mid-day trading on Friday . The stock traded as low as GBX 3.63 ($0.04) and last traded at GBX 3.63 ($0.04). Approximately 113,328 shares traded hands during mid-day trading, a decline of 86% from the average daily volume of 833,830 shares. The stock had previously closed at GBX 4 ($0.05).
Verici Dx Stock Performance
The business’s 50-day simple moving average is GBX 3.55 and its 200 day simple moving average is GBX 5.03. The firm has a market cap of £8.79 million, a P/E ratio of -181.25 and a beta of 1.59. The company has a debt-to-equity ratio of 4.65, a quick ratio of 8.49 and a current ratio of 4.54.
About Verici Dx
Verici Dx is a developer of a complementary suite of leading-edge tests forming a kidney transplant platform for personalised patient and organ response risk to assist clinicians in medical management for improved patient outcomes. The underlying technology is based upon artificial intelligence assisted transcriptomic analysis to provide RNA signatures focused upon the immune response and other biological pathway signals critical for transplant prognosis of risk of injury, rejection and graft failure from pre-transplant to late stage.
Featured Articles
- Five stocks we like better than Verici Dx
- EV Stocks and How to Profit from Them
- Nebius Group: Market Overreaction or Real AI Disruption?
- Most Volatile Stocks, What Investors Need to Know
- The Best Way to Invest in Gold Is…
- How to Calculate Retirement Income: MarketBeat’s Calculator
- Why Nike Stock Could Be 2025’s Top Comeback Play
Receive News & Ratings for Verici Dx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Verici Dx and related companies with MarketBeat.com's FREE daily email newsletter.
